Antigenic Polypeptides
AssigneeBiosynexus Incorporated
InventorsSimon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising said polypeptides; recombinant methods to manufacture said polypeptides; and therapeutic antibodies directed to said polypeptides.
Claims17
An immunogenic composition comprising a carrier or adjuvant and at least one isolated polypeptide comprising all or a portion of SEQ ID NO.:
- 27.
A method of preparing an immune globulin for use in prevention or treatment of staphylococcal infection comprising the step of immunizing a recipient with an immunogenic composition comprising a carrier or adjuvant and at least one isolated polypeptide comprising all or a portion of SEQ ID NO.:
- 27, and isolating an immune globulin from the recipient.
A method of inducing an immune response to Staphylococcus aureus in a subject, comprising administering to said subject an immunogenic composition comprising a carrier or adjuvant and at least one isolated polypeptide comprising all or a portion of SEQ ID NO.:
- 27.
Dependencies are inferred from the claim text.